๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anticentromere antibody

โœ Scribed by Gale Anne Mccarty; John R. Rice; Mary L. Bembe; Franc A. Barada Jr.


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
671 KB
Volume
26
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

โœฆ Synopsis


The presence of antibody to the chromosomal centromere appears to be associated with a subset of patients with the limited CREST form of scleroderma. To further define the prognostic value of this autoantibody, 27 patients, who were identified as having anticentromere antibody by screening antinuclear antibody tests using HEp-2 cell substrates, were followed clinically and serologically for 2 years. The presence of anticentromere antibody is common in the limited CREST forms of systemic sclerosis, and it is often the only autoantibody specificity present in the sera of patients with the CREST variant. When compared with other patients who exhibit speckled or nucleolar antinuclear antibody patterns, those with anticentromere antibody had significantly less major organ system involvement.

The introduction of tissue culture substrates for the detection of antinuclear antibodies (ANA) has revealed a diversity of specificities in the sera of patients with scleroderma and its variants (1-3). Previ-From the Division of Rheumatic and Genetic Diseases,


๐Ÿ“œ SIMILAR VOLUMES


Anticentromere antibody โ€” clinical assoc
โœ P. Caramaschi; T. Manzo; D. Biasi; A. Carletto; F. Poli; L. M. Bambara ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 303 KB

The objective of this study was to determine the clinical features of 44 patients with anticentromere antibody (ACA) positivity. We undertook a retrospective review of 44 ACA-positive patients (1 male and 43 females with a mean +/- SD age of 53.6 +/- 12.2 years). There were 25 patients with limited

Anticentromere antibody and pulmonary hy
โœ Robert M. Bernstein; Ronald A. Asherson; Celia M. Oakley; Graham R. V. Hughes ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB
Anticentromere-protein-B-DNA complex act
โœ Y. Muro; Y. Matsumoto; M. Ohashi ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 354 KB

Centromere protein B (CENP-B), which is an alphoid DNA binding protein, is the target antigen in autoimmune disease patients (often those with scleroderma). In this study, we analysed activities of anti-CENP-B-DNA complex in anticentromere antibody (ACA)-positive patients using DNA immunoprecipitati

Anticentromere antibodies in primary bil
โœ Drew Makinen; Marvin Fritzler; Dr Paul Davis; Sheila Sherlock ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB ๐Ÿ‘ 1 views
A long-term longitudinal study of antice
โœ Helen D. Tramposch; C. Douglas Smith; Jean-Luc Senecal; Dr. Naomi Rothfield ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 384 KB ๐Ÿ‘ 1 views

A longitudinal retrospective study of 37 patients previously tested for anticentromere antibodies (ACA) in 1982 was carried out. No ACA were found in stored sera from 22 ACA-negative patients including 1 patient with CREST (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, tel